# Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder

> **NCT07330648** · PHASE2 · RECRUITING · sponsor: **Anhui Medical University** · enrollment: 216 (estimated)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DRUG:** Crisugabalin 20mg bid
- **DRUG:** Venlafaxine-XR 75mg bid
- **DRUG:** Crisugabalin capsules mimic 0mg/capsule bid

## Key facts

- **NCT ID:** NCT07330648
- **Lead sponsor:** Anhui Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-10
- **Primary completion:** 2027-01-31
- **Final completion:** 2027-02-28
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07330648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07330648, "Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07330648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*